| Risk factors for amyotrophic lateral sclerosis C Ingre, PM Roos, F Piehl, F Kamel, F Fang Clinical epidemiology, 181-193, 2015 | 553 | 2015 |
| A yeast functional screen predicts new candidate ALS disease genes J Couthouis, MP Hart, J Shorter, M DeJesus-Hernandez, R Erion, ... Proceedings of the National Academy of Sciences 108 (52), 20881-20890, 2011 | 451 | 2011 |
| Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients T Lee, YR Li, C Ingre, M Weber, T Grehl, O Gredal, M de Carvalho, ... Human molecular genetics 20 (9), 1697-1700, 2011 | 168 | 2011 |
| Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20‐year follow‐up of the Swedish AMORIS cohort D Mariosa, N Hammar, H Malmström, C Ingre, I Jungner, W Ye, F Fang, ... Annals of neurology 81 (5), 718-728, 2017 | 137 | 2017 |
| Depression in amyotrophic lateral sclerosis E Roos, D Mariosa, C Ingre, C Lundholm, K Wirdefeldt, PM Roos, F Fang Neurology 86 (24), 2271-2277, 2016 | 107 | 2016 |
| Altered perivascular fibroblast activity precedes ALS disease onset A Månberg, N Skene, F Sanders, M Trusohamn, J Remnestål, ... Nature medicine 27 (4), 640-646, 2021 | 96 | 2021 |
| The Swedish motor neuron disease quality registry E Longinetti, A Regodón Wallin, K Samuelsson, R Press, A Zachau, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19 (7-8), 528-537, 2018 | 89 | 2018 |
| A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts C Ingre, JE Landers, N Rizik, AE Volk, C Akimoto, A Birve, A Hübers, ... Neurobiology of aging 34 (6), 1708. e1-1708. e6, 2013 | 86 | 2013 |
| July 2017 ENCALS statement on edaravone A Al-Chalabi, PM Andersen, S Chandran, A Chio, P Corcia, P Couratier, ... Amyotrophic lateral sclerosis and frontotemporal degeneration 18 (7-8), 471-474, 2017 | 58 | 2017 |
| Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis C Ingre, L Chen, Y Zhan, J Termorshuizen, L Yin, F Fang Neurology 94 (17), e1835-e1844, 2020 | 56 | 2020 |
| Predictors of health-related quality of life in people with amyotrophic lateral sclerosis P Sandstedt, S Johansson, C Ytterberg, C Ingre, LW Holmqvist, ... Journal of the Neurological Sciences 370, 269-273, 2016 | 56 | 2016 |
| Blood biomarkers and prognosis of amyotrophic lateral sclerosis J Sun, JJ Carrero, U Zagai, M Evans, C Ingre, Y Pawitan, F Fang European Journal of Neurology 27 (11), 2125-2133, 2020 | 51 | 2020 |
| Antibiotics use and risk of amyotrophic lateral sclerosis in Sweden J Sun, Y Zhan, D Mariosa, H Larsson, C Almqvist, C Ingre, U Zagai, ... European Journal of Neurology 26 (11), 1355-1361, 2019 | 50 | 2019 |
| Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis E Longinetti, D Mariosa, H Larsson, W Ye, C Ingre, C Almqvist, ... Neurology 89 (6), 578-585, 2017 | 49 | 2017 |
| Amyotrophic lateral sclerosis among cross-country skiers in Sweden F Fang, U Hållmarker, S James, C Ingre, K Michaëlsson, A Ahlbom, ... European journal of epidemiology 31, 247-253, 2016 | 49 | 2016 |
| Military service and related risk factors for amyotrophic lateral sclerosis KA McKay, KA Smith, L Smertinaite, F Fang, C Ingre, F Taube Acta Neurologica Scandinavica 143 (1), 39-50, 2021 | 41 | 2021 |
| Complications and outcome of percutaneous endoscopic gastrostomy in a high-volume centre M Vujasinovic, C Ingre, F Baldaque Silva, F Frederiksen, J Yu, P Elbe Scandinavian journal of gastroenterology 54 (4), 513-518, 2019 | 41 | 2019 |
| T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression S Yazdani, C Seitz, C Cui, A Lovik, L Pan, F Piehl, Y Pawitan, U Kläppe, ... Nature communications 13 (1), 6733, 2022 | 39 | 2022 |
| Peripheral immune biomarkers and neurodegenerative diseases: a prospective cohort study with 20 years of follow‐up S Yazdani, D Mariosa, N Hammar, J Andersson, C Ingre, G Walldius, ... Annals of neurology 86 (6), 913-926, 2019 | 31 | 2019 |
| Homozygous SMN2 deletion is a protective factor in the Swedish ALS population P Corcia, C Ingre, H Blasco, R Press, J Praline, C Antar, ... European journal of human genetics 20 (5), 588-591, 2012 | 30 | 2012 |
